These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 10265081)

  • 1. An antitrust exemption for commercial insurers? Answer: no.
    Goldberg LG; Greenberg W
    Rev Fed Am Hosp; 1984; 17(1):84, 87. PubMed ID: 10265081
    [No Abstract]   [Full Text] [Related]  

  • 2. Federal antitrust exemption, state laws combine to protect insurers.
    Horty JF
    Mod Healthc; 1982 Feb; 12(2):129-30. PubMed ID: 10254275
    [No Abstract]   [Full Text] [Related]  

  • 3. Court decisions expand industry's antitrust exposure.
    Waxman JM
    Rev Fed Am Hosp; 1982; 15(5):52-3. PubMed ID: 10256503
    [No Abstract]   [Full Text] [Related]  

  • 4. Antitrust and affiliations among healthcare providers: the need for a level playing field.
    Heightchew A
    Hosp Health Serv Adm; 1997; 42(4):559-65. PubMed ID: 10174466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Court's ruling could cripple peer review.
    Geisel J
    Bus Insur; 1982 Jul; 16(28):1, 44. PubMed ID: 10255884
    [No Abstract]   [Full Text] [Related]  

  • 6. Supreme court rules that an agreement between insurer and a peer review organization is not exempt from antitrust scrutiny.
    Moses RJ
    Health Law Vigil; 1982 Jul; 5(15):4-5. PubMed ID: 10256012
    [No Abstract]   [Full Text] [Related]  

  • 7. New sheriff in town. Health insurers take antitrust enforcement matters into own hands with litany of lawsuits.
    Taylor M
    Mod Healthc; 2001 Dec; 31(49):26-8. PubMed ID: 11765364
    [No Abstract]   [Full Text] [Related]  

  • 8. Health insurance industry shouldn't be exempt from antitrust laws.
    Goldberg LG; Greenberg W
    Healthspan; 1991 May; 8(5):3-9. PubMed ID: 10111989
    [No Abstract]   [Full Text] [Related]  

  • 9. The McCarran-Ferguson Act's antitrust exemption for insurance: language, history and policy.
    Weller CD
    Duke Law J; 1978 May; (2):587-643. PubMed ID: 10239067
    [No Abstract]   [Full Text] [Related]  

  • 10. Supreme Court's decision adds little to antitrust analysis.
    Miles JJ
    Health Law Vigil; 1986 Jun; 9(12):12-4. PubMed ID: 10276709
    [No Abstract]   [Full Text] [Related]  

  • 11. Group life & Health Insurance Co. v. Royal Drug Co.: the McCarran-Ferguson Act and Health Service Plans.
    Szabo DS
    Am J Law Med; 1980; 5(4):393-413. PubMed ID: 7377202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Participation agreements between providers and third-party insurers withstand antitrust challenges in two recent federal district court cases.
    O'Brien JP
    Health Law Vigil; 1981 Aug; 4(17):2-5. PubMed ID: 10252308
    [No Abstract]   [Full Text] [Related]  

  • 13. Too big? Caremark, AdvancePCS getting close look from feds.
    Becker C
    Mod Healthc; 2004 Jan; 34(2):14, 16. PubMed ID: 14959629
    [No Abstract]   [Full Text] [Related]  

  • 14. Business of insurance and antitrust: some case history.
    Weissburg C; Waxman JM
    Rev Fed Am Hosp; 1981; 14(4):42-4. PubMed ID: 10252197
    [No Abstract]   [Full Text] [Related]  

  • 15. Tenth Circuit upholds HHS experimental competitive bidding proposal for Medicare intermediary services; defers to "reasonable" agency readings of law.
    Kemezys KP
    Health Law Vigil; 1981 Dec; 4(25):7-9. PubMed ID: 10298342
    [No Abstract]   [Full Text] [Related]  

  • 16. The privacy implications of insurers' information practices.
    Skipper H
    J Risk Insur; 1979 Mar; 46(1):9-32. PubMed ID: 10241429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Judge acknowledges broad antitrust exemption for California hospital districts.
    Christensen JD
    Health Law Vigil; 1988 Mar; 11(7):1-3. PubMed ID: 10286395
    [No Abstract]   [Full Text] [Related]  

  • 18. Confidentiality: insurers balance needs against privacy considerations.
    Orsini LA
    Internist; 1978 Mar; 19(2):8-9. PubMed ID: 10306830
    [No Abstract]   [Full Text] [Related]  

  • 19. Insurance companies and McCarran-Ferguson Act--the ADA position.
    Umeda GT
    Hawaii Dent J; 2009; 40(5):4-6, 11. PubMed ID: 20415093
    [No Abstract]   [Full Text] [Related]  

  • 20. Competition and antitrust enforcement in the changing pharmaceutical marketplace.
    Whitener MD
    Food Drug Law J; 1995; 50(2):301-7. PubMed ID: 10342998
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.